Risk of Incident Cancer in Patients With Inflammatory Bowel Disease With Prior Breast Cancer: A Multicenter Cohort Study

This publication has 29 references indexed in Scilit:

• Risk of Cancer Recurrence in Patients With Immune-Mediated Diseases With Use of Immunosuppressive Therapies: An Updated Systematic Review and Meta-Analysis
  Clinical Gastroenterology and Hepatology, 2023
• Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study
  Clinical Gastroenterology and Hepatology, 2023
• I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease
  Clinical Gastroenterology and Hepatology, 2022
• Vedolizumab or Tumor Necrosis Factor Antagonist Use and Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease With Prior Malignancy: A Retrospective Cohort Study
  Clinical Gastroenterology and Hepatology, 2022
• Inflammatory breast cancer: early recognition and diagnosis is critical
  American Journal of Obstetrics and Gynecology, 2021
• Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases
  Clinical Gastroenterology and Hepatology, 2019
• Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease
  JAMA, 2017
• Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study
  Arthritis & Rheumatology, 2016
• Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents
  Clinical Gastroenterology and Hepatology, 2016
• Survival in Danish patients with breast cancer and inflammatory bowel disease: A nationwide cohort study
  Inflammatory Bowel Diseases, 2008